The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries

Abstract Background Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antenatal corticosteroids (ACS) prevent mortality and respiratory morbidity when ad...

Full description

Bibliographic Details
Main Author: WHO ACTION Trials Collaborators
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Trials
Subjects:
Antenatal corticosteroids
Late preterm birth
Dexamethasone
Betamethasone
Low- resource setting
Online Access:https://doi.org/10.1186/s13063-024-07941-0

Internet

https://doi.org/10.1186/s13063-024-07941-0

Similar Items